rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1993-8-5
|
pubmed:abstractText |
To evaluate the efficacy of low-dose oral recombinant interferon-alpha (IFN-alpha A) on clinical parameters, body weight, CD4+ lymphocyte counts and natural killer cell cytolytic activity in HIV-infected patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0269-9370
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
693-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8100421-Administration, Oral,
pubmed-meshheading:8100421-Adult,
pubmed-meshheading:8100421-CD4-Positive T-Lymphocytes,
pubmed-meshheading:8100421-Cytotoxicity, Immunologic,
pubmed-meshheading:8100421-Drug Tolerance,
pubmed-meshheading:8100421-Female,
pubmed-meshheading:8100421-HIV Infections,
pubmed-meshheading:8100421-HIV-1,
pubmed-meshheading:8100421-Humans,
pubmed-meshheading:8100421-Interferon-alpha,
pubmed-meshheading:8100421-Killer Cells, Natural,
pubmed-meshheading:8100421-Leukocyte Count,
pubmed-meshheading:8100421-Male,
pubmed-meshheading:8100421-Recombinant Proteins
|
pubmed:year |
1993
|
pubmed:articleTitle |
Low-dose oral recombinant interferon-alpha A in patients with HIV-1 infection: a blinded pilot study.
|
pubmed:affiliation |
Department of Medicine, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|